Literature DB >> 19948376

Histone acetyltransferase p300 is a coactivator for transcription factor REL and is C-terminally truncated in the human diffuse large B-cell lymphoma cell line RC-K8.

Michael R Garbati1, Gökçen Alço, Thomas D Gilmore.   

Abstract

Human c-Rel (REL) is a member of the NF-kappaB family of transcription factors. REL's normal physiological role is in the regulation of B-cell proliferation and survival. The REL gene is amplified in many human B-cell lymphomas and overexpression of REL can transform chicken lymphoid cells. In this report, histone acetyltransferase p300 enhanced REL-induced transactivation and interacted with REL both in vitro and in REL-transformed chicken spleen cells and the B-lymphoma cell line RC-K8, in which REL is constitutively active and required for proliferation. However, due to a deletion in the EP300 locus, only a C-terminally truncated form of p300 is expressed in RC-K8 cells. These results suggest a role for p300 in REL-mediated oncogenic activity in B lymphoma.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19948376      PMCID: PMC2849871          DOI: 10.1016/j.canlet.2009.10.018

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  43 in total

1.  Deletion of either C-terminal transactivation subdomain enhances the in vitro transforming activity of human transcription factor REL in chicken spleen cells.

Authors:  Daniel T Starczynowski; Joseph G Reynolds; Thomas D Gilmore
Journal:  Oncogene       Date:  2003-10-09       Impact factor: 9.867

2.  Histone acetyltransferase activity of p300 enhances the activation of IL-12 p40 promoter.

Authors:  Haijing Sun; Jun Lu; Liang Wei; Xiuli Wang; Xin Xu; Mei Dong; Baiqu Huang
Journal:  Mol Immunol       Date:  2004-11       Impact factor: 4.407

3.  De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling.

Authors:  Ingrid E Wertz; Karen M O'Rourke; Honglin Zhou; Michael Eby; L Aravind; Somasekar Seshagiri; Ping Wu; Christian Wiesmann; Rohan Baker; David L Boone; Averil Ma; Eugene V Koonin; Vishva M Dixit
Journal:  Nature       Date:  2004-07-18       Impact factor: 49.962

Review 4.  CBP and p300: HATs for different occasions.

Authors:  Eric Kalkhoven
Journal:  Biochem Pharmacol       Date:  2004-09-15       Impact factor: 5.858

5.  Stimulation of c-Rel transcriptional activity by PKA catalytic subunit beta.

Authors:  Shih-Hung Yu; Wei-Chung Chiang; Hsiu-Ming Shih; Kou-Juey Wu
Journal:  J Mol Med (Berl)       Date:  2004-06-09       Impact factor: 4.599

6.  Human interleukin-5 expression is synergistically regulated by histone acetyltransferase CBP/p300 and transcription factors C/EBP, NF-AT and AP-1.

Authors:  Chunyan Liu; Jun Lu; Jiang Tan; Lin Li; Baiqu Huang
Journal:  Cytokine       Date:  2004 Aug 21-Sep 7       Impact factor: 3.861

Review 7.  The c-Rel transcription factor and B-cell proliferation: a deal with the devil.

Authors:  Thomas D Gilmore; Demetrios Kalaitzidis; Mei-Chih Liang; Daniel T Starczynowski
Journal:  Oncogene       Date:  2004-03-25       Impact factor: 9.867

Review 8.  p300/CBP and cancer.

Authors:  Narayanan Gopalakrishna Iyer; Hilal Ozdag; Carlos Caldas
Journal:  Oncogene       Date:  2004-05-24       Impact factor: 9.867

9.  Distinct roles for CREB-binding protein and p300 in hematopoietic stem cell self-renewal.

Authors:  Vivienne I Rebel; Andrew L Kung; Elizabeth A Tanner; Hong Yang; Roderick T Bronson; David M Livingston
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-23       Impact factor: 11.205

10.  Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large B-cell lymphoma.

Authors:  Mara Compagno; Wei Keat Lim; Adina Grunn; Subhadra V Nandula; Manisha Brahmachary; Qiong Shen; Francesco Bertoni; Maurilio Ponzoni; Marta Scandurra; Andrea Califano; Govind Bhagat; Amy Chadburn; Riccardo Dalla-Favera; Laura Pasqualucci
Journal:  Nature       Date:  2009-05-03       Impact factor: 49.962

View more
  17 in total

Review 1.  Bromodomain coactivators in cancer, obesity, type 2 diabetes, and inflammation.

Authors:  Gerald V Denis
Journal:  Discov Med       Date:  2010-12       Impact factor: 2.970

2.  Characterization of the core elements of the NF-κB signaling pathway of the sea anemone Nematostella vectensis.

Authors:  Francis S Wolenski; Michael R Garbati; Tristan J Lubinski; Nikki Traylor-Knowles; Erica Dresselhaus; Derek J Stefanik; Haley Goucher; John R Finnerty; Thomas D Gilmore
Journal:  Mol Cell Biol       Date:  2010-12-28       Impact factor: 4.272

3.  BCL6 repression of EP300 in human diffuse large B cell lymphoma cells provides a basis for rational combinatorial therapy.

Authors:  Leandro C Cerchietti; Katerina Hatzi; Eloisi Caldas-Lopes; Shao Ning Yang; Maria E Figueroa; Ryan D Morin; Martin Hirst; Lourdes Mendez; Rita Shaknovich; Philip A Cole; Kapil Bhalla; Randy D Gascoyne; Marco Marra; Gabriela Chiosis; Ari Melnick
Journal:  J Clin Invest       Date:  2010-11-01       Impact factor: 14.808

Review 4.  Epigenetics and B-cell lymphoma.

Authors:  Rita Shaknovich; Ari Melnick
Journal:  Curr Opin Hematol       Date:  2011-07       Impact factor: 3.284

5.  The c-Rel Transcription Factor in Development and Disease.

Authors:  Thomas D Gilmore; Steve Gerondakis
Journal:  Genes Cancer       Date:  2011-07

6.  A rearranged EP300 gene in the human B-cell lymphoma cell line RC-K8 encodes a disabled transcriptional co-activator that contributes to cell growth and oncogenicity.

Authors:  Michael R Garbati; Ryan C Thompson; Leila Haery; Thomas D Gilmore
Journal:  Cancer Lett       Date:  2011-01-12       Impact factor: 8.679

7.  Murine leukemia retrovirus integration induces the formation of transcription factor complexes on palindromic sequences in the signal transducer and activator of transcription factor 5a gene during the development of pre-B lymphomagenesis.

Authors:  Tatsuaki Tsuruyama; Takuya Hiratsuka; Guang Jin; Yukiko Imai; Haruya Takeuchi; Yasuhiro Maruyama; Kazuya Kanaya; Munetaka Ozeki; Tetsuya Takakuwa; Hironori Haga; Keiji Tamaki; Takuro Nakamura
Journal:  Am J Pathol       Date:  2011-03       Impact factor: 4.307

Review 8.  The epigenetic basis of diffuse large B-cell lymphoma.

Authors:  Yanwen Jiang; Ari Melnick
Journal:  Semin Hematol       Date:  2015-01-19       Impact factor: 3.851

9.  The oncoprotein HBXIP modulates the feedback loop of MDM2/p53 to enhance the growth of breast cancer.

Authors:  Hang Li; Qian Liu; Zhen Wang; Runping Fang; Yu Shen; Xiaoli Cai; Yuen Gao; Yinghui Li; Xiaodong Zhang; Lihong Ye
Journal:  J Biol Chem       Date:  2015-07-30       Impact factor: 5.157

10.  Evidence for an oncogenic modifier role for mutant histone acetyltransferases in diffuse large B-cell lymphoma.

Authors:  Leila Haery; Sultan Mussakhan; David J Waxman; Thomas D Gilmore
Journal:  Leuk Lymphoma       Date:  2016-03-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.